Profile data is unavailable for this security.
About the company
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
- Revenue in USD (TTM)1.13bn
- Net income in USD14.23m
- Incorporated2004
- Employees4.20k
- LocationPenumbra IncOne Penumbra PlaceALAMEDA 94502United StatesUSA
- Phone+1 (510) 748-3200
- Fax+1 (302) 531-3150
- Websitehttps://www.penumbrainc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Procept Biorobotics Corp | 176.58m | -103.71m | 4.37bn | 626.00 | -- | 17.52 | -- | 24.75 | -2.06 | -2.06 | 3.50 | 4.85 | 0.546 | 1.85 | 3.83 | 282,068.70 | -32.07 | -- | -36.52 | -- | 54.73 | -- | -58.73 | -- | 6.49 | -- | 0.1696 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
DENTSPLY SIRONA Inc | 3.90bn | -185.00m | 5.33bn | 15.00k | -- | 1.74 | 32.50 | 1.37 | -0.8698 | -0.8698 | 18.65 | 15.12 | 0.5356 | 2.94 | 6.18 | 259,733.30 | -2.49 | -1.14 | -3.03 | -1.32 | 52.23 | 53.65 | -4.65 | -2.51 | 0.8692 | 3.65 | 0.4066 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
TransMedics Group Inc | 358.76m | 3.00m | 5.50bn | 584.00 | 3,999.03 | 28.95 | 316.38 | 15.34 | 0.0413 | 0.0413 | 10.61 | 5.70 | 0.4952 | 3.56 | 5.58 | 614,313.40 | 0.4141 | -16.08 | 0.4403 | -17.95 | 60.71 | 65.37 | 0.8362 | -40.47 | 8.48 | -- | 0.7278 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
Merit Medical Systems Inc | 1.30bn | 117.43m | 5.80bn | 6.95k | 49.63 | 4.52 | 27.23 | 4.45 | 2.01 | 2.01 | 22.24 | 22.04 | 0.6183 | 2.30 | 7.36 | 187,231.10 | 5.58 | 2.45 | 6.13 | 2.77 | 46.54 | 44.50 | 9.02 | 3.91 | 4.64 | 17.52 | 0.3846 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
Stevanato Group SpA | 1.21bn | 136.81m | 5.83bn | 5.64k | 37.50 | 3.56 | 25.73 | 4.80 | 0.5136 | 0.5136 | 4.54 | 5.42 | 0.543 | 2.66 | 2.80 | 215,440.70 | 6.12 | -- | 8.34 | -- | 30.06 | -- | 11.27 | -- | 1.13 | 44.77 | 0.1926 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
Inspire Medical Systems Inc | 705.71m | 6.01m | 6.35bn | 1.01k | 1,099.89 | 9.94 | 644.81 | 8.99 | 0.1935 | 0.1935 | 23.74 | 21.41 | 1.05 | 2.68 | 9.86 | 698,026.70 | 0.8927 | -11.27 | 0.99 | -12.60 | 84.83 | 84.47 | 0.8518 | -13.57 | 8.35 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
Masimo Corp | 2.02bn | 79.40m | 6.49bn | 3.80k | 82.59 | 4.72 | 37.18 | 3.22 | 1.47 | 1.47 | 37.32 | 25.73 | 0.6831 | 1.94 | 5.77 | 530,763.20 | 2.69 | 8.65 | 3.32 | 10.31 | 49.28 | 57.30 | 3.94 | 12.03 | 1.15 | 3.30 | 0.3635 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
Glaukos Corp | 341.73m | -158.61m | 7.02bn | 907.00 | -- | 10.53 | -- | 20.55 | -3.20 | -3.20 | 6.91 | 12.13 | 0.3642 | 1.67 | 7.55 | 376,764.10 | -16.91 | -8.73 | -18.20 | -9.35 | 76.53 | 74.77 | -46.41 | -28.69 | 4.67 | -56.93 | 0.16 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
Penumbra Inc | 1.13bn | 14.23m | 7.57bn | 4.20k | 571.01 | 6.52 | 174.64 | 6.68 | 0.3415 | 0.3415 | 28.94 | 29.90 | 0.7642 | 1.07 | 5.53 | 269,924.50 | 0.9595 | 2.32 | 1.07 | 2.61 | 65.45 | 63.90 | 1.26 | 3.17 | 3.77 | -- | 0.0209 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
Lantheus Holdings Inc | 1.44bn | 428.48m | 7.64bn | 834.00 | 18.02 | 7.44 | 15.64 | 5.31 | 6.11 | 6.11 | 20.48 | 14.79 | 0.8775 | 8.35 | 4.58 | 1,724,234.00 | 26.15 | 6.69 | 29.96 | 7.73 | 64.49 | 57.56 | 29.80 | 9.02 | 4.41 | -- | 0.3546 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
Repligen Corp | 602.35m | -1.90m | 8.01bn | 1.78k | -- | 4.02 | 116.73 | 13.29 | -0.0416 | -0.0416 | 10.67 | 35.53 | 0.2226 | 1.46 | 4.95 | 337,831.80 | -0.0703 | 4.38 | -0.0782 | 5.03 | 47.70 | 55.43 | -0.3156 | 15.91 | 5.56 | -- | 0.2282 | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
Henry Schein, Inc. | 12.49bn | 352.00m | 9.02bn | 25.00k | 26.30 | 2.57 | 14.29 | 0.722 | 2.71 | 2.71 | 95.98 | 27.64 | 1.29 | 4.88 | 8.25 | 499,480.00 | 3.58 | 6.09 | 5.97 | 10.44 | 31.63 | 30.04 | 2.78 | 4.40 | 0.896 | 6.85 | 0.3333 | 0.00 | -2.44 | 5.55 | -22.68 | -0.1456 | 21.27 | -- |
Bio Rad Laboratories Inc | 2.56bn | -1.33bn | 9.18bn | 8.03k | -- | 1.37 | -- | 3.58 | -47.03 | -47.03 | 89.18 | 240.39 | 0.2366 | 1.49 | 5.47 | 319,128.80 | -12.24 | 9.08 | -12.87 | 9.60 | 54.02 | 55.55 | -51.73 | 41.97 | 4.63 | 0.1653 | 0.1504 | 0.00 | -4.67 | 3.13 | 82.43 | -- | 3.83 | -- |
Globus Medical Inc | 2.24bn | 40.68m | 9.57bn | 5.00k | 237.98 | 2.40 | 35.52 | 4.28 | 0.2968 | 0.2968 | 17.02 | 29.38 | 0.6207 | 1.63 | 5.25 | 447,306.00 | 1.13 | 6.90 | 1.30 | 7.45 | 59.65 | 71.73 | 1.82 | 14.05 | 1.45 | 455.56 | 0.098 | 0.00 | 53.34 | 17.08 | -35.39 | -4.72 | 5.57 | -- |
Bruker Corp | 3.12bn | 352.10m | 10.23bn | 9.71k | 28.11 | 5.71 | 20.63 | 3.28 | 2.40 | 2.40 | 21.24 | 11.82 | 0.6393 | 1.47 | 5.90 | 321,386.60 | 7.21 | 8.38 | 9.59 | 11.40 | 50.08 | 49.85 | 11.28 | 11.39 | 0.7244 | 43.06 | 0.5419 | 9.81 | 17.14 | 9.36 | 44.03 | 18.91 | 16.79 | 4.56 |
Holder | Shares | % Held |
---|---|---|
Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 5.06m | 13.06% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 3.63m | 9.38% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 3.46m | 8.91% |
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2024 | 2.98m | 7.69% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.20m | 3.11% |
Capital Research & Management Co. (Global Investors)as of 31 Mar 2024 | 1.13m | 2.92% |
Champlain Investment Partners LLCas of 31 Mar 2024 | 1.08m | 2.80% |
William Blair Investment Management LLCas of 30 Jun 2024 | 841.65k | 2.17% |
ClearBridge Investments LLCas of 31 Mar 2024 | 786.34k | 2.03% |
FIAM LLCas of 31 Mar 2024 | 743.32k | 1.92% |